Evidence map›Paper›PMID 38870118›Full record

ArticlePloS one2024

An oral toxicity assessment of a mosquito larvicidal transgenic algae (Chlamydomonas reinhardtii) using adult Zebrafish and its embryos.

Fareeha Amjad, Hamza Khan, Muhammad Islam Khan, Sidra Ayub, Rashid Bhatti, Rabbia Pervaiz, Kausar Malik, Mohsin Ahmad Khan

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Fareeha AmjadNutraceuticals and Microbial Biotechnology Lab, National Center of Excellence in Molecular Biology (CEMB), University of the Punjab, Lahore, Pakistan.ORCID 0000-0002-3169-0791
Hamza KhanNutraceuticals and Microbial Biotechnology Lab, National Center of Excellence in Molecular Biology (CEMB), University of the Punjab, Lahore, Pakistan.
Muhammad Islam KhanNutraceuticals and Microbial Biotechnology Lab, National Center of Excellence in Molecular Biology (CEMB), University of the Punjab, Lahore, Pakistan.
Sidra AyubNutraceuticals and Microbial Biotechnology Lab, National Center of Excellence in Molecular Biology (CEMB), University of the Punjab, Lahore, Pakistan.
Rashid BhattiNutraceuticals and Microbial Biotechnology Lab, National Center of Excellence in Molecular Biology (CEMB), University of the Punjab, Lahore, Pakistan.
Rabbia PervaizQarshi University, Lahore, Pakistan.
Kausar MalikNutraceuticals and Microbial Biotechnology Lab, National Center of Excellence in Molecular Biology (CEMB), University of the Punjab, Lahore, Pakistan.
Mohsin Ahmad KhanNutraceuticals and Microbial Biotechnology Lab, National Center of Excellence in Molecular Biology (CEMB), University of the Punjab, Lahore, Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mosquito-borne diseases pose a global health threat, with pathogens like Malaria, Dengue fever, and others transmitted by mosquitoes. Our study focuses on evaluating the toxicity of genetically engineered mosquito larvicidal algae (Chlamydomonas reinhardtii) to non-target organisms, specifically Zebrafish. We conducted a 90-day experiment, feeding Zebrafish different combinations of larvicidal algae and commercial fish feed. Statistical analysis revealed no significant differences in mortality, allergenicity, or moribundity among groups. Hematology, molecular analysis, and necropsy showed no physiological differences. Our findings indicate that the transgenic algae (TN72.cry11Ba) had no adverse effects on adult Zebrafish or their larvae. This study confirmed the safety of algae on non-target organisms, such as zebrafish.

Indexed as

Chlamydomonas reinhardtiiLarvaZebrafishAdministration, OralAnimalsCulicidaeEmbryo, NonmammalianInsecticidesInsecticides

Identifiers

PMID38870118
PMCPMC11175461

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.